Elite in Stridor

Padmaja Subbarao

555 University Avenue, 
Toronto, ON, CA 
Elite in Stridor
555 University Avenue, 
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Padmaja Subbarao practices in Toronto, Canada. Ms. Subbarao is rated as an Elite expert by MediFind in the treatment of Stridor. Her top areas of expertise are Stridor, Asthma, Asthma in Children, and Cystic Fibrosis.

Her clinical research consists of co-authoring 228 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 25 articles and participated in 1 clinical trial in the study of Stridor.

Gender
Female

Locations

555 University Avenue, Toronto, ON, Canada
Other Locations
27 King's College Circle, Toronto, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Vitamin D In the Prevention of Viral-induced Asthma in Preschoolers: a Randomized Controlled Multicenter Trial (DIVA)
Vitamin D In the Prevention of Viral-induced Asthma in Preschoolers: a Randomized Controlled Multicenter Trial (DIVA)
Enrollment Status: Completed
Publish Date: June 03, 2025
Intervention Type: Dietary supplement
Study Drug: Vitamin D
Study Phase: Phase 3
The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children
The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children
Enrollment Status: Completed
Publish Date: February 08, 2021
Intervention Type: Procedure, Drug
View 1 Less Clinical Trial

228 Total Publications

Human milk IgA promotes normal immune development by limiting Th17-inducing Erysipelatoclostridium ramosum in the infant gut.
Human milk IgA promotes normal immune development by limiting Th17-inducing Erysipelatoclostridium ramosum in the infant gut.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Subbarao's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile